Green Oaks, IL, United States of America

Tami J Pilot-Matias

This inventor holds 23 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Antiviral Compounds. Top assignees: Abbott Laboratories Corporation, Abbvie Inc.. Active years: 1997-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tami J Pilot-Matias. Retrieved from https://idiyas.com/inventor/tami-j-pilot-matias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 95.7

 

 

Average Co-Inventor Count = 7.6

ph-index = 10

Forward Citations = 204(Granted Patents)


Location History:

  • Libertyville, IL (US) (1997 - 1999)
  • Green Oaks, IL (US) (1998 - 2019)

Company Filing History:


Years Active: 1997-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thiazoles
Anti-Viral Compounds
HCV Treatment
Hepatitis Reagents
Borrelia Burgdorferi
Synthetic Peptides
Recombinant Proteins
TT Virus
23 patents (USPTO):Explore Patents

Title: The Innovative Journey of Tami J Pilot-Matias

Introduction: Tami J Pilot-Matias is a pioneering inventor based in Green Oaks, IL (US) known for her groundbreaking contributions to various industries.

Latest Patents: Tami J Pilot-Matias holds several patents in the fields of technology and healthcare, showcasing her versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Tami J Pilot-Matias has consistently pushed the boundaries of innovation, leading to significant advancements in her areas of expertise.

Collaborations: Throughout her career, Tami J Pilot-Matias has collaborated with leading researchers, engineers, and professionals, fostering a culture of innovation and excellence.

Conclusion: Tami J Pilot-Matias's dedication to innovation and her remarkable contributions have solidified her reputation as a trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…